A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The DHX36-specific-motif (DSM) enhances specificity by accelerating recruitment of DNA G-quadruplex structures.
Bruce Chang-Gu, Devin Bradburn, Philip M Yangyuoru, Rick Russell. Biol Chem 2020
1
100

Regulation of RNA helicase activity: principles and examples.
Pascal Donsbach, Dagmar Klostermeier. Biol Chem 2021
2
50

Regulation of DEAH-box RNA helicases by G-patch proteins.
Katherine E Bohnsack, Ralf Ficner, Markus T Bohnsack, Stefanie Jonas. Biol Chem 2021
8
50



Mtr4 RNA helicase structures and interactions.
Keith J Olsen, Sean J Johnson. Biol Chem 2021
4
50


Re-emergence of acute myeloid leukemia in donor cells following allogeneic transplantation in a family with a germline DDX41 mutation.
G Berger, E van den Berg, B Sikkema-Raddatz, K M Abbott, R J Sinke, L B Bungener, A B Mulder, E Vellenga. Leukemia 2017
41
50

Excessive R-loops trigger an inflammatory cascade leading to increased HSPC production.
Joshua T Weinreb, Noura Ghazale, Kith Pradhan, Varun Gupta, Kathryn S Potts, Brad Tricomi, Noah J Daniels, Richard A Padgett, Sofia De Oliveira, Amit Verma,[...]. Dev Cell 2021
14
50

Germline heterozygous DDX41 variants in a subset of familial myelodysplasia and acute myeloid leukemia.
S R Cardoso, G Ryan, A J Walne, A Ellison, R Lowe, H Tummala, A Rio-Machin, L Collopy, A Al Seraihi, Y Wallis,[...]. Leukemia 2016
36
50

Advances in germline predisposition to acute leukaemias and myeloid neoplasms.
Jeffery M Klco, Charles G Mullighan. Nat Rev Cancer 2021
29
50

Novel germline missense DDX41 variant in a patient with an adult-onset myeloid neoplasm with excess blasts without dysplasia.
Filippo Pinto E Vairo, Alejandro Ferrer, Elizabeth Cathcart-Rake, Rebecca L King, Matthew T Howard, David S Viswanatha, Eric W Klee, Abhishek A Mangaonkar, Mrinal M Patnaik. Leuk Lymphoma 2019
6
50

DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease.
Andrés E Quesada, Mark J Routbort, Courtney D DiNardo, Carlos E Bueso-Ramos, Rashmi Kanagal-Shamanna, Joseph D Khoury, Beenu Thakral, Zhuang Zuo, C Cameron Yin, Sanam Loghavi,[...]. Am J Hematol 2019
32
50

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
John S Welch, Allegra A Petti, Christopher A Miller, Catrina C Fronick, Michelle O'Laughlin, Robert S Fulton, Richard K Wilson, Jack D Baty, Eric J Duncavage, Bevan Tandon,[...]. N Engl J Med 2016
462
50

Novel DDX41 variants in Thai patients with myeloid neoplasms.
Chantana Polprasert, June Takeda, Pimjai Niparuck, Thanawat Rattanathammethee, Arunrat Pirunsarn, Amornchai Suksusut, Sirorat Kobbuaklee, Kitsada Wudhikarn, Panisinee Lawasut, Sunisa Kongkiatkamon,[...]. Int J Hematol 2020
7
50

Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms.
Chantana Polprasert, Isabell Schulze, Mikkael A Sekeres, Hideki Makishima, Bartlomiej Przychodzen, Naoko Hosono, Jarnail Singh, Richard A Padgett, Xiaorong Gu, James G Phillips,[...]. Cancer Cell 2015
197
50

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
Pierre Fenaux, Ghulam J Mufti, Eva Hellstrom-Lindberg, Valeria Santini, Carlo Finelli, Aristoteles Giagounidis, Robert Schoch, Norbert Gattermann, Guillermo Sanz, Alan List,[...]. Lancet Oncol 2009
50

Unique ethnic features of DDX41 mutations in patients with idiopathic cytopenia of undetermined significance, myelodysplastic syndrome, or acute myeloid leukemia.
Eun-Ji Choi, Young-Uk Cho, Eun-Hye Hur, Seongsoo Jang, Nayoung Kim, Han-Seung Park, Jung-Hee Lee, Kyoo-Hyung Lee, Si-Hwan Kim, Sang-Hyun Hwang,[...]. Haematologica 2022
4
50

Identification of spliceosome components pivotal to breast cancer survival.
Jing An, Zhehui Luo, Weiwei An, Difei Cao, Jianli Ma, Zhaoliang Liu. RNA Biol 2021
4
50

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Daniel A Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J Borowitz, Michelle M Le Beau, Clara D Bloomfield, Mario Cazzola, James W Vardiman. Blood 2016
50

Biological implications of somatic DDX41 p.R525H mutation in acute myeloid leukemia.
Moe Kadono, Akinori Kanai, Akiko Nagamachi, Satoru Shinriki, Jin Kawata, Koji Iwato, Taiichi Kyo, Kumi Oshima, Akihiko Yokoyama, Takeshi Kawamura,[...]. Exp Hematol 2016
22
50

Recurrent genetic defects on chromosome 5q in myeloid neoplasms.
Naoko Hosono, Hideki Makishima, Reda Mahfouz, Bartlomiej Przychodzen, Kenichi Yoshida, Andres Jerez, Thomas LaFramboise, Chantana Polprasert, Michael J Clemente, Yuichi Shiraishi,[...]. Oncotarget 2017
24
50

Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.
Cristina Andrés-Zayas, Julia Suárez-González, Gabriela Rodríguez-Macías, Nieves Dorado, Santiago Osorio, Patricia Font, Diego Carbonell, María Chicano, Paula Muñiz, Mariana Bastos,[...]. Mol Oncol 2021
2
50

Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations.
Sarah A Bannon, Mark J Routbort, Guillermo Montalban-Bravo, Rohtesh S Mehta, Fatima Zahra Jelloul, Koichi Takahashi, Naval Daver, Betul Oran, Naveen Pemmaraju, Gautam Borthakur,[...]. Front Oncol 2021
5
50

Identifying patients with genetic predisposition to acute myeloid leukemia.
Ellyn Obrochta, Lucy A Godley. Best Pract Res Clin Haematol 2018
14
50

Two novel germline DDX41 mutations in a family with inherited myelodysplasia/acute myeloid leukemia.
Ruijuan Li, Nara Sobreira, P Dane Witmer, Keith W Pratz, Evan M Braunstein. Haematologica 2016
32
50

Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
Zhenhua Qi, Fang Yan, Dongtai Chen, Wei Xing, Qiang Li, Weian Zeng, Bingtian Bi, Jingdun Xie. Biosci Rep 2020
18
50

Myeloid neoplasms with germline DDX41 mutation.
Jesse J C Cheah, Christopher N Hahn, Devendra K Hiwase, Hamish S Scott, Anna L Brown. Int J Hematol 2017
42
50

The emerging roles of the DDX41 protein in immunity and diseases.
Yan Jiang, Yanping Zhu, Zhi-Jie Liu, Songying Ouyang. Protein Cell 2017
40
50


Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.
Michael W Drazer, Sabah Kadri, Madina Sukhanova, Sushant A Patil, Allison H West, Simone Feurstein, Dalein A Calderon, Matthew F Jones, Caroline M Weipert, Christopher K Daugherty,[...]. Blood Adv 2018
47
50

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
50

Successful lenalidomide treatment in high risk myelodysplastic syndrome with germline DDX41 mutation.
Iman Abou Dalle, Hagop Kantarjian, Sarah A Bannon, Rashmi Kanagal-Shamanna, Mark Routbort, Keyur P Patel, Shimin Hu, Kapil Bhalla, Guillermo Garcia-Manero, Courtney D DiNardo. Am J Hematol 2020
8
50

Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
Courtney D DiNardo, Sarah A Bannon, Mark Routbort, Anna Franklin, Maureen Mork, Mary Armanios, Emily M Mace, Jordan S Orange, Meselle Jeff-Eke, Jane E Churpek,[...]. Clin Lymphoma Myeloma Leuk 2016
49
50

Germline DDX41 mutations define a significant entity within adult MDS/AML patients.
Marie Sébert, Marie Passet, Anna Raimbault, Ramy Rahmé, Emmanuel Raffoux, Flore Sicre de Fontbrune, Marco Cerrano, Samuel Quentin, Nadia Vasquez, Mélanie Da Costa,[...]. Blood 2019
51
50

Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.
Maya Lewinsohn, Anna L Brown, Luke M Weinel, Connie Phung, George Rafidi, Ming K Lee, Andreas W Schreiber, Jinghua Feng, Milena Babic, Chan-Eng Chong,[...]. Blood 2016
107
50

Genetics of MDS.
Seishi Ogawa. Blood 2019
115
50

DDX41-related myeloid neoplasia.
Jaroslaw P Maciejewski, Richard A Padgett, Anna L Brown, Carsten Müller-Tidow. Semin Hematol 2017
27
50



Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study.
Yu Wang, Qi-Fa Liu, Lan-Ping Xu, Kai-Yan Liu, Xiao-Hui Zhang, Xiao Ma, Zhi-Ping Fan, De-Pei Wu, Xiao-Jun Huang. Blood 2015
266
50

Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study.
Takahiko Yasuda, Masashi Sanada, Dai Nishijima, Takashi Kanamori, Yuka Iijima, Hiroyoshi Hattori, Akiko Saito, Hiroaki Miyoshi, Yuichi Ishikawa, Norio Asou,[...]. Cancer Sci 2020
6
50

Identification of Novel Genetic Variants in CVID Patients With Autoimmunity, Autoinflammation, or Malignancy.
Mette Christiansen, Rasmus Offersen, Jens Magnus Bernth Jensen, Mikkel Steen Petersen, Carsten S Larsen, Trine H Mogensen. Front Immunol 2020
14
50


Germline Predisposition to Hematolymphoid Neoplasia.
Olga K Weinberg, Frank Kuo, Katherine R Calvo. Am J Clin Pathol 2019
9
50

Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer.
Deepak Singhal, Christopher N Hahn, Simone Feurstein, Li Yan A Wee, Luke Moma, Monika M Kutyna, Rakchha Chhetri, Leila Eshraghi, Andreas W Schreiber, Jinghua Feng,[...]. Leukemia 2021
8
50

Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary.
Attila Péter Király, Krisztián Kállay, Ambrus Gángó, Ádám Kellner, Miklós Egyed, Anita Szőke, Richárd Kiss, István Vályi-Nagy, Judit Csomor, András Matolcsy,[...]. Pathol Oncol Res 2018
6
50

Prevalence and clinical implications of germline predisposition gene mutations in patients with acute myeloid leukemia.
Borahm Kim, Woobin Yun, Seung-Tae Lee, Jong Rok Choi, Keon Hee Yoo, Hong Hoe Koo, Chul Won Jung, Sun Hee Kim. Sci Rep 2020
9
50

New dead/H-box helicase gene (ddx41) mutation in an Italian family with recurrent leukemia.
Francesca Fazio, Martina Quintini, Ida Carmosino, Caterina Matteucci, Eleonora Miulli, Fabrizia Pellanera, Benedetta Lucani, Michela Ansuinelli, Massimo Breccia, Cristina Mecucci,[...]. Leuk Lymphoma 2021
1
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.